Achieving deeper insights into the crosstalk between GR and p38 might therefore not only provide means to combat GC resistance but may also provide new therapy options for diseases like neuropathy and acute pancreatitis in the future. This evidence concerns the gene MAPK1 and acute pancreatitis.